Sino Biological Inc
SZSE:301047

Watchlist Manager
Sino Biological Inc Logo
Sino Biological Inc
SZSE:301047
Watchlist
Price: 65.6 CNY -4.32% Market Closed
Market Cap: 8.2B CNY
Have any thoughts about
Sino Biological Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Sino Biological Inc

Current Assets 4.5B
Cash & Short-Term Investments 4.2B
Receivables 166.2m
Other Current Assets 98.7m
Non-Current Assets 1.8B
Long-Term Investments 436.5m
PP&E 909.4m
Intangibles 337.3m
Other Non-Current Assets 160.7m
Current Liabilities 174.3m
Accounts Payable 17.2m
Accrued Liabilities 41.9m
Other Current Liabilities 115.2m
Non-Current Liabilities 97.5m
Long-Term Debt 48.9m
Other Non-Current Liabilities 48.6m

Balance Sheet
Sino Biological Inc

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
6
10
56
2 872
2 379
1 288
Cash
0
0
0
2 863
2 349
1 259
Cash Equivalents
6
10
56
9
30
28
Short-Term Investments
13
42
1 073
3 638
3 422
3 533
Total Receivables
29
49
199
159
148
133
Accounts Receivables
28
46
194
153
140
126
Other Receivables
1
3
5
6
7
7
Inventory
11
12
14
25
47
53
Other Current Assets
6
4
17
24
27
63
Total Current Assets
65
117
1 359
6 719
6 024
5 069
PP&E Net
28
49
52
123
246
916
PP&E Gross
28
49
52
123
246
916
Accumulated Depreciation
18
26
36
59
94
142
Intangible Assets
0
1
0
1
1
1
Long-Term Investments
0
0
0
0
180
450
Other Long-Term Assets
12
20
54
48
129
164
Total Assets
106
N/A
187
+77%
1 465
+683%
6 890
+370%
6 580
-4%
6 601
+0%
Liabilities
Accounts Payable
9
13
13
13
29
19
Accrued Liabilities
10
14
63
37
45
55
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
20
20
23
Other Current Liabilities
8
6
85
28
31
38
Total Current Liabilities
26
33
161
98
125
136
Long-Term Debt
0
0
0
27
51
62
Deferred Income Tax
0
4
6
13
30
31
Other Liabilities
0
0
0
0
6
4
Total Liabilities
27
N/A
37
+40%
166
+346%
138
-17%
211
+53%
234
+11%
Equity
Common Stock
5
5
51
68
129
129
Retained Earnings
49
86
1 089
1 809
1 432
1 434
Additional Paid In Capital
25
59
142
4 853
4 793
4 796
Other Equity
0
0
17
22
15
8
Total Equity
79
N/A
150
+90%
1 299
+767%
6 752
+420%
6 369
-6%
6 367
0%
Total Liabilities & Equity
106
N/A
187
+77%
1 465
+683%
6 890
+370%
6 580
-4%
6 601
+0%
Shares Outstanding
Common Shares Outstanding
129
129
129
129
129
129

See Also

Discover More